Hair Loss Signals Emerge in FDA Database as Biologics Draw New Safety Scrutiny
An analysis of six years of FDA adverse event reports finds disproportionately high reporting odds of hair loss among patients ...
An analysis of six years of FDA adverse event reports finds disproportionately high reporting odds of hair loss among patients ...
A new cross-sectional survey study reveals how diagnoses of autoimmune connective tissue diseases and their treatments shape patients' decisions about ...
A Yale study found that a simple educational pamphlet significantly improved gastrointestinal cancer patients' knowledge of the skin, hair, and ...
A cross-sectional analysis of the NIH All of Us Research Program examines whether hypertensive patients with psoriasis are prescribed different ...
A cross-sectional analysis using the NIH All of Us Research Program compares the clinical characteristics and lifestyle factors of Black ...
A specialty clinic survey published in the Archives of Dermatological Research examines how hidradenitis suppurativa patients perceive their access to ...
A new review maps how point-of-care ultrasound could transform the diagnosis, staging, and treatment of hidradenitis suppurativa while cautioning that ...
A linked electronic health record and claims analysis of 401 US patients shows most begin abrocitinib at 100 mg, refill ...
A study of 1,297 patients with androgenetic alopecia found serum trace element levels were within normal ranges and essentially indistinguishable ...
A new retrospective study by Stony Brook University researchers uses the TriNetX real-world data network to estimate how many Americans ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine